Jump to content
Advertisement

Advertisement

Google-FDA accepts application to add IBS-C indication for Trulance - Healio


Health Reporter
 Share

Recommended Posts


Advertisement

FDA accepts application to add IBS-C indication for Trulance
Healio
The FDA has accepted Synergy Pharmaceuticals' supplemental new drug application to add constipation-predominant irritable bowel syndrome as an indication for Trulance, the company announced.
FDA to Review Trulance for IBS-C Indication in AdultsMonthly Prescribing Reference (registration)
Synergy Pharmaceuticals Announces Acceptance of Supplemental New Drug Application (sNDA) for TRULANCE ...Business Wire (press release)
BRIEF-Synergy Pharmaceuticals says acceptance of SNDA for TRULANCE for treatment of adults with irritable bowel ...Reuters
Benchmark Monitor
all 6 news articles »

View the full article



Advertisement
Link to post
Share on other sites

 Share

×
×
  • Create New...